GregoryPiazzaMD

Cardiology • Boston, MA

Adult Congenital Heart Disease

Instructor in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Piazza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Piazza's full profile

Already have an account?

Office
75 Francis St
Boston, MA 02115
Phone+1 617-732-6632

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2004 - 2008
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Massachusetts Medical SchoolClass of 2001

Certifications & Licensure

ME State Medical License Current
MA State Medical License 2003 - 2026
FL State Medical License 2022 - 2025
NH State Medical License 2022 - 2024
RI State Medical License 2022 - 2024
VT State Medical License 2023 - 2024
CT State Medical License 2022 - 2023
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

Electronic Alerts for Stroke Prevention in Atrial Fibrillation Start of enrollment: 2018 Jun 01
Completed
Not Applicable
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Start of enrollment: 2018 Feb 28
Completed
Phase 4
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) Start of enrollment: 2019 Feb 01
Recruiting
Not Applicable
Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism Start of enrollment: 2019 Mar 01
Active, not recruiting
Not Applicable
Quantitative 3-Dimensional Chest CT Vascular Reconstruction Before and After Anticoagulation for Pulmonary Embolism Start of enrollment: 2019 Dec 01
Recruiting
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism Start of enrollment: 2021 Mar 01
Active, not recruiting
Phase 4
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications Start of enrollment: 2020 Mar 24
Recruiting
Fertility, Hypercoagulability, and Inflammation (FREYA) Registry Start of enrollment: 2018 Apr 01
Active, not recruiting
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management Start of enrollment: 2021 Oct 08
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator
Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus Start of enrollment: 2022 Dec 01
Recruiting
Not Applicable
Roles: Principal Investigator
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy Start of enrollment: 2023 Mar 01
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE Start of enrollment: 2024 Jun 30
Not yet recruiting
Not Applicable
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

94 citations
Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review.
Romain Chopard, Ida Ehlers Albertsen, Gregory Piazza
JAMA. 2020-11-03
25 citations
Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.
Thure Filskov Overvad, Anne Gulbech Ording, Peter Brønnum Nielsen, Flemming Skjøth, Ida Ehlers Albertsen
Blood Advances. 2022-05-24
20 citations
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.
Samuel Z. Goldhaber, Brian G. Engelhardt, Javid Moslehi, Madan Jagasia, Daryl Patton
Frontiers in Oncology. 2019-02-26

Journal Articles

Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction
Gregory Piazza, MD, Thrombosis and Haemostasis

Lectures

Case 3: Interventional Treatment of Acute Pulmonary Emboli
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
VTE Challenges: A Case-Based Panel Discussion
2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019
Peripheral Vascular Disease Highlights Session
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Highlights in Venous Thromboembolism
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Welcome and Introduction of Panelists
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Panelist: Case 2
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all

Press Mentions

Virtual, Cloud-Based PREVENT-HD Trial Evaluates Rivaroxaban To Prevent Thrombosis in COVID-19 PatientsMay 16th, 2023
Feature | Science Highlights from AHA 2022December 2nd, 2022
Anticoagulation Again Flops for Outpatient COVID-19November 8th, 2022
Join now to see all